
Professor Zofia Miedzybrodzka
MB ChB, PhD, FRCP Edin, FRCOG
Personal Chair (Clinical)
- About
-
Medical Genetics
Room 2:041
Polwarth Building
Foresterhill
Aberdeen
AB25 2ZDBiography
Zosia Miedzybrodzka is Professor of Medical Genetics at the University of Aberdeen. She is also honorary consultant clinical geneticist and Service Clinical Director of Genetics for NHS Grampian (comprising Clinical Services and diagnostic DNA and cytogenetics laboratories), and co-director of the University of Aberdeen Centre for Genome-enabled Biology and Medicine.
Her areas of work place her on the interface between Clinical Practice and Research. her interests lie in the application of genetic techology to medicine. Current projects focus on genetic biomarkers for treatment response in gastro-oesophageal cancer, genetics and care in Huntington's disease, improving delivery of familial hypercholesterolaemia services. She is lead for NHS implementation within the Scottish Genomes Project. Currently she is Chair of the Scottish Clinical Genetics Forum and specialty adviser to the Chief Medical Officer for clinical genetics.
- Publications
-
Page 1 of 15 Results 1 to 10 of 141
Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer
Cancers, vol. 14, no. 13, 3175Contributions to Journals: ArticlesEvaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service
British Journal of CancerContributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/s41416-022-01724-7
The known burden of Huntington disease in the north of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era
Journal of Neurology, vol. 268, pp. 4170-4177Contributions to Journals: ArticlesHuntington's disease: northern Scotland has one of the world's highest rates and rising sharply - here's why
The ConversationContributions to Specialist Publications: ArticlesContinuing the sequence?: Towards an Economic Evaluation of Whole Genome Sequencing for the Diagnosis of Rare Diseases in Scotland
Journal of Community GeneticsContributions to Journals: ArticlesCreation and Worldwide Utilisation of New COVID-19 Online Information Hub for Genetics Health Professionals, Patients and Families
Frontiers in Genetics, vol. 12, 621683Contributions to Journals: ArticlesOptimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Clinical Cancer Research, vol. 27, no. 11, pp. 3126-3140Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1158/1078-0432.CCR-20-0121
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Nature Communications, vol. 12, no. 1, 1078Contributions to Journals: ArticlesInteractions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed
Cancer Chemotherapy and Pharmacology, vol. 87, pp. 361–377Contributions to Journals: ArticlesGenetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women
Nature Communications, vol. 11, no. 1, 5976Contributions to Journals: Articles